Literature DB >> 18957946

Etanercept for patients with RA: more is not always better.

Joel M Kremer1.   

Abstract

Entities:  

Year:  2008        PMID： 18957946     DOI： 10.1038/ncprheum0936

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  3 in total

1.  Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.

Authors:  Thierry Dervieux; Daniel Furst; Diana Orentas Lein; Robert Capps; Katie Smith; Michael Walsh; Joel Kremer
Journal:  Arthritis Rheum       Date:  2004-09

2.  Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.

Authors:  Michael E Weinblatt; Michael H Schiff; Eric M Ruderman; Clifton O Bingham; Juan Li; James Louie; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-07

3.  Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

Authors:  A M van Gestel; M L Prevoo; M A van 't Hof; M H van Rijswijk; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1996-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.